Bvf Inc Angion Biomedica Corp. Transaction History

Bvf Inc

  • $3.27 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
BUY
$9.31 - $13.25 $323,960 - $461,060
34,797 Added 3.36%
1,071,297 $10.5 Million
Q2 2021

Aug 16, 2021
BUY
$13.02 - $17.83 $2.1 Million - $2.88 Million
161,500 Added 18.46%
1,036,500 $13.5 Million
Q1 2021

May 17, 2021
BUY
$15.01 - $25.74 $13.1 Million - $22.5 Million
875,000 New
875,000 $15.8 Million

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email